Medical researchers conducted the largest-ever genome-wide association study of all-cause dementia, finding substantial genetic overlap with vascular dementia.

New research suggests that the lessening of amyloid-beta in the brain is behind cognitive decline in Alzheimer's and boosting ...

The Alzheimer's Foundation of America will host a free Alzheimer's & Caregiving Educational Conference for Connecticut ...

Alzheimer’s Alliance of Smith County helped spread awareness with a pinwheel garden set outside of CHRISTUS Mother Frances Hospital on Friday.

The study identifies lower potassium isotope ratios in Alzheimer's patients, suggesting δ41K as a viable biomarker for early ...

Scientists say that excessive light pollution may increase the risk of Alzheimer's, especially in younger people.

Optimizing iPSC differentiation significantly improves in vitro Alzheimer's disease models, leading to more accurate and ...

Alzheimer’s disease research and drug development is evolving at a rapid pace. Decades of research has led to the approval of the first disease-modifying drugs and new pathological discoveries.

Alzheimer’s disease (Alzheimer’s) is conceptualized as a progressive consequence of two hallmark pathological changes in gray matter, in particular, extracellular amyloid plaques and neurofibrillary ...

Alzheimer’s disease slowly takes over the mind. Long before symptoms occur, brain cells are gradually losing their function. Eventually they wither away, eroding brain networks that store memories.